November 26, 2019 / 10:59 PM / 11 days ago

J&J loses bid to overturn $76.6 million Risperdal injury award

A Pennsylvania appeals court on Tuesday upheld a $76.6 million jury award to a man who claimed he developed breasts after using Johnson & Johnson’s antipsychotic drug Risperdal as a child and cleared the way for him to seek punitive damages.

The Pennsylvania Superior Court rejected J&J’s arguments that Andrew Yount’s claims under Tennessee law that the drugmaker failed to warn of the drug’s risks were preempted by federal law.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below